NMRA vs UAL · $283.5M cap vs P/E 10, rev $57.06B
Neumora Therapeutics, Inc. (NMRA) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
NMRA does not have a complete income-statement cache yet.
Latest reported UAL revenue for 2024-12-31 was $57.06B. Net income was $3.15B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
NMRA currently screens at market cap $283.5M. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the NMRA and UAL stock pages for the full models.
Not investment advice.